Call Options

5 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2023

May 15, 2023

SELL
$0.56 - $1.15 $2,800 - $5,750
-5,000 Closed
0 $0
Q4 2022

Feb 14, 2023

SELL
$1.08 - $2.35 $4,320 - $9,400
-4,000 Reduced 80.0%
1,000 $1,000
Q3 2022

May 15, 2023

BUY
$0.43 - $4.31 $1,720 - $17,240
4,000 Added 400.0%
5,000 $11,000
Q3 2022

Nov 14, 2022

SELL
$0.43 - $4.31 $4,730 - $47,409
-11,000 Reduced 68.75%
5,000 $12,000
Q2 2022

Aug 15, 2022

BUY
$2.81 - $12.91 $44,960 - $206,560
16,000 New
16,000 $54,000

Others Institutions Holding CELU

About Celularity Inc


  • Ticker CELU
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 142,424,000
  • Market Cap $319M
  • Description
  • Celularity Inc., a clinical-stage biotechnology company, develops off-the-shelf placental-derived allogeneic cell therapies for the treatment of cancer, immune, and infectious diseases. It operates through three segments: Cell Therapy, Degenerative Disease, and BioBanking. The company's lead therapeutic programs include CYCART-19, a placental-de...
More about CELU
Track This Portfolio

Track Sg3 Management, LLC Portfolio

Follow Sg3 Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg3 Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg3 Management, LLC with notifications on news.